Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma

被引：3
|
作者：
Noorduyn, Stephen G. [1 ,2 ]
Johnston, Karissa [3 ,4 ]
Osenenko, Kathy [3 ]
Sriskandarajah, Niroshan [1 ]
Gendron, Alain [5 ]
Mbuagbaw, Lawrence [2 ]
机构：
[1] AstraZeneca Canada Ltd, Mississauga, ON, Canada
[2] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
[3] Broadstreet HEOR, Vancouver, BC, Canada
[4] Mem Univ, St John, NF, Canada
[5] Univ Montreal, Dept Med, Montreal, PQ, Canada
来源：
ERJ OPEN RESEARCH | 2021年 / 7卷 / 04期
关键词：
D O I：
10.1183/23120541.00465-2021
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Efficacy of Benralizumab in patients with severe eosinophilic asthma
    Soto Hurtado, E.
    Rodriguez Gallego, Y.
    Arzola Rodriguez, M.
    [J]. PNEUMOLOGIE, 2023, 77 : S25 - S26
  • [2] Benralizumab (Fasenra) for Severe Eosinophilic Asthma
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1541): : 33 - 35
  • [3] Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma
    Somekawa, Kohei
    Watanabe, Keisuke
    Seki, Kenichi
    Muraoka, Suguru
    Izawa, Ami
    Kaneko, Ayami
    Otsu, Yukiko
    Hirata, Momo
    Kubo, Sousuke
    Tanaka, Katsushi
    Nagasawa, Ryo
    Matsumoto, Hiromi
    Murohashi, Kota
    Fuji, Hiroaki
    Aoki, Ayako
    Horita, Nobuyuki
    Hara, Yu
    Kobayashi, Nobuaki
    Kudo, Makoto
    Kaneko, Takeshi
    [J]. EUROPEAN CLINICAL RESPIRATORY JOURNAL, 2024, 11 (01):
  • [4] Use of CompEx in eosinophilic patients with severe, uncontrolled asthma on benralizumab
    Bolton, Clare
    Harrison, Tim
    Lugogo, Njira
    Fuhlbrigge, Anne
    Hirsch, Ian
    Bengtsson, Thomas
    Peterson, Stefan
    Sidaway, Martin
    Gil, Esther Garcia
    Fageras, Malin
    Da Silva, Carla A.
    [J]. ERJ OPEN RESEARCH, 2024, 10 (02)
  • [5] Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis
    Nolasco, Santi
    Crimi, Claudia
    Campisi, Raffaele
    Cacopardo, Giulia
    Intravaia, Rossella
    Porto, Morena
    Crimi, Nunzio
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [6] Effect of benralizumab on the immune response in patients with severe eosinophilic asthma
    Sematonyte, J.
    Bajoriuniene, I
    Sitkauskiene, B.
    [J]. ALLERGY, 2019, 74 : 364 - 364
  • [7] BENRALIZUMAB IMPROVES RESPIRATORY RESISTANCE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Badal, T.
    Cottee, A.
    Seccombe, L.
    Reed, N.
    Farah, C.
    [J]. RESPIROLOGY, 2020, 25 : 210 - 210
  • [8] OUTCOMES WITH MEPOLIZUMAB AND BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Elsey, L.
    Hince, K.
    Aspin, P.
    Pantin, C. T.
    Allen, D.
    Niven, R.
    Fowler, S. J.
    Tavernier, G.
    [J]. THORAX, 2021, 76 : A142 - A142
  • [9] Personalized Approach of Severe Eosinophilic Asthma Patients Treated with Mepolizumab and Benralizumab
    Bergantini, Laura
    d'Alessandro, Miriana
    Cameli, Paolo
    Bianchi, Francesco
    Sestini, Piersante
    Bargagli, Elena
    Refini, Rosa Metella
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2020, 181 (10) : 746 - 753
  • [10] COMPREHENSIVE RESPONSE TO BENRALIZUMAB BY PATIENTS WITH NASAL POLYPOSIS AND SEVERE, EOSINOPHILIC ASTHMA
    Kreindler, J.
    Chanez, P.
    Bourdin, A.
    Burden, A.
    Garcia Gil, E.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S29 - S29
12345